CIGB-300, a synthetic peptide-based drug that targets the CK2 phosphoaceptor domain. Translational and clinical research - Concepedia

Concepedia

Publication | Closed Access

CIGB-300, a synthetic peptide-based drug that targets the CK2 phosphoaceptor domain. Translational and clinical research

43

Citations

14

References

2011

Year

Silvio E. Perea, Idania Baladrón, Yanelda García, Yasser Perera, Adlín López, Jorge Luis Soriano, Noyde Batista, A. Palau, Ignacio Hernández, Hernán G. Fariña,

Molecular and Cellular Biochemistry

Molecular PharmacologySignal TransductionCk2 Phosphoaceptor DomainMedicinePeptide LibraryPeptide TherapeuticPeptide SciencePeptide TherapeuticsSynthetic Peptide-based DrugPharmacologyCell BiologyCell SignalingNovel TherapyDrug DiscoveryMolecular Signaling

References

	Year	Citations

Page 1

Page 1